Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 1250.00 | 580.08 | 1833.00 | 1814.50 | 1.0102 | 1.0124 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1886.00 | 1814.50 | 1.0394 | 1.0475 | |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 1904.00 | 1814.50 | 1.0493 | 1.0594 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 1250.00 | 580.08 | 1672.00 | 1814.50 | 0.9215 | 0.9030 |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 1636.00 | 1814.50 | 0.9016 | 0.8780 |
| BT-20 | Erlotinib | 1 | uM | 7 | 1250.00 | 580.08 | 1723.00 | 1814.50 | 0.9496 | 0.9381 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 1250.00 | 580.08 | 1042.00 | 1814.50 | 0.5743 | 0.4276 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 1250.00 | 580.08 | 1824.00 | 1814.50 | 1.0052 | 1.0064 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1917.00 | 1814.50 | 1.0565 | 1.0679 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 1250.00 | 580.08 | 605.00 | 1814.50 | 0.3334 | 0.0259 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1631.00 | 1814.50 | 0.8989 | 0.8745 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 4.00 | 1814.50 | 0.0022 | -0.9514 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 3.00 | 1814.50 | 0.0017 | -0.9592 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1781.00 | 1814.50 | 0.9815 | 0.9775 | |
| BT-20 | 17-AAG | 10 | uM | 7 | 1250.00 | 580.08 | 619.00 | 1814.50 | 0.3411 | 0.0403 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 1250.00 | 580.08 | 1607.00 | 1814.50 | 0.8856 | 0.8577 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 1250.00 | 580.08 | 1874.00 | 1814.50 | 1.0328 | 1.0396 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 1250.00 | 580.08 | 2015.00 | 1814.50 | 1.1105 | 1.1316 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 2001.00 | 1814.50 | 1.1028 | 1.1225 | |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 1250.00 | 580.08 | 1796.00 | 1814.50 | 0.9898 | 0.9876 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 1250.00 | 580.08 | 1893.00 | 1814.50 | 1.0433 | 1.0522 |
| BT-20 | Linsitinib | 1 | uM | 7 | 1250.00 | 580.08 | 1885.00 | 1814.50 | 1.0389 | 1.0469 |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 1250.00 | 580.08 | 1810.00 | 1814.50 | 0.9975 | 0.9970 |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 1250.00 | 580.08 | 1939.00 | 1814.50 | 1.0686 | 1.0823 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 1250.00 | 580.08 | 718.00 | 1814.50 | 0.3957 | 0.1384 |